Catalyst
Slingshot members are tracking this event:
FDA Grants Priority Review for Genentech’s Cancer Immunotherapy Atezolizumab in Specific Type of Lung Cancer
Do you think this event is important to the companies below? How will it affect their stock price?
| Related Companies | Importance
|
Impact on Stocks
|
||||
|---|---|---|---|---|---|---|
| RHHBY | Community voting in process | |||||
Slingshot Insights Explained
Catalyst Date
Occurred on:
Apr 11, 2016
Related Projects
-
Don’t see a project related to the catalyst you care about?
Related Keywords
Anti-pdl, Mpdl3280a, Nsclc, Programmed Death Ligand-1, Platinum-containing Chemotherapy
